Foghorn Therapeutics, Inc. FHTX 深 沪
等待开盘 10-06 09:30:00 美东时间
2.00
-0.020
-0.99%
华盛通- 最 高7.35
- 今 开2.03
- 成交量 86.28万股
- 最 低 1.79
- 昨 收 2.02
- 总市值 8.29万
- 52周最高 7.61
- 市盈率 静 --
- 换手率 2080.65%
- 52周最低 1.79
- 委 比 -7.59%
- 总股本 4.15万
- 历史最高 28.265
- 量 比 0.25
- 振 幅 275.25%
- 历史最低 1.10
- 每 手 1
- 风险率 0.82%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多TD Cowen Downgrades Foghorn Therapeutics to Hold
TD Cowen analyst Yaron Werber downgrades Foghorn Therapeutics (NASDAQ:FHTX) from Buy to Hold.
10-02 22:23
Nasdaq Gains 100 Points; ISM manufacturing PMI Slips In September
U.S. stocks edged higher Thursday; Nasdaq rose 0.37%, energy led gains, Accenture surged 18%, and Corteva plunged 84%.
10-02 01:54
Foghorn Therapeutics Pivots Pipeline after Ending Eli Lilly Deal
Foghorn Therapeutics stock drops as Eli Lilly ends partnership, prompting a 40% workforce cut to extend cash runway into 2029 while pivoting pipeline.
10-02 00:17
Foghorn Therapeutics to Participate in Four Upcoming Investor Conferences
Foghorn Therapeutics announced its participation in multiple virtual and in-person healthcare conferences, where CEO Adrian Gottschalk will deliver presentations and engage in discussions on the company's innovative approach to treating diseases through correcting abnormal gene expression.
2025-05-22 11:00
Morgan Stanley Maintains Equal-Weight on Foghorn Therapeutics, Raises Price Target to $9
Morgan Stanley analyst Vikram Purohit maintains Foghorn Therapeutics (NASDAQ:FHTX) with a Equal-Weight and raises the price target from $6 to $9.
2024-09-24 19:29
Jefferies Initiates Foghorn Therapeutics at Buy
06:29 AM EDT, 09/03/2024 (MT Newswires) -- Foghorn Therapeutics (FHTX) has average rating of outperform and price targets ranging from $6 to $20, according to analysts polled by Capital IQ. (MT Newswires covers equity, commodity and economic research from major banks and research firms in North Amer...
2024-09-03 18:29
Why Nikola Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Nikola Corporation (NASDAQ:NKLA) fell sharply in Monday's session after the company announced it entered into a securities purchase agreement and filed for a mixed shelf offering. Nikola shares dipped 10.4% to $7.28 on Monday. Here are some other stocks moving in today’s mid-day session. G...
2024-08-20 01:37
